Evidence map›Paper›PMID 21637346›Full record

ArticlePloS one2011

Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients.

Denise Lasigliè, Elisabetta Traggiai, Silvia Federici, Maria Alessio, Antonella Buoncompagni, Andrea Accogli, Sabrina Chiesa, Federica Penco, Alberto Martini, Marco Gattorno

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Frontiers in immunology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Clinical implications of asthma endotypes and phenotypes.Allergy and asthma proceedings · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. The Gut Microbiota: A Novel Player in Autoimmune Hepatitis.Frontiers in cellular and infection microbiology · 2022
    Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Denise LasiglièRheumatology Unit, Second Division of Pediatrics G. Gaslini Institute, Genoa, Italy.
Elisabetta Traggiai
Silvia Federici
Maria Alessio
Antonella Buoncompagni
Andrea Accogli
Sabrina Chiesa
Federica Penco
Alberto Martini
Marco Gattorno
Istituto Giannina Gaslini · ITUniversity of Genoa · ITFederico II University Hospital · IT

Funding

Telethon GGP09127
6 · The paper itself

Abstract

backgroundT helper 17 cells (T(H)-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to T(H)-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. METHODOLOGY/PRINCIPAL

findingsA total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T(H)17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T(H)17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T(H)17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T(H)17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. CONCLUSION/SIGNIFICANCE: These findings further support the central role of IL-1β in the differentiation of T(H)17 in human inflammatory conditions.

Indexed as

AdolescentAdultArthritis, JuvenileCarrier ProteinsChildChild, PreschoolCryopyrin-Associated Periodic SyndromesDendritic CellsFemaleHumansImmunologic MemoryInfantInterferon-gammaInterleukin-17Interleukin-1betaInterleukin-23 Subunit p19Carrier ProteinsCCR6 protein, humanIL17A protein, humanIL1B protein, humanIL23A protein, humanIL6 protein, humanInterferon-gammaInterleukin-17Interleukin-1betaInterleukin-23 Subunit p19Interleukin-6KLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily BNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanReceptors, CCR6

Identifiers

PMID21637346
PMCPMC3102666
OpenAlexW2093739574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.